ARMAVIR PARTNERS
ArmaVir Partners, formerly the Ramius Private Investments Group makes direct equity investments in operating companies and unique assets. It takes an active approach and makes control or significant minority investments in small-to-mid-sized operating companies. It also looks to make minority investments in select high growth private companies. In 2018, Armavir Partners spun out of its former parent, Cowen Inc. ArmaVir Partners has over $300 million in assets under management. ArmaVir Partners is actively seeking new investment opportunities in North America and Western Europe. Typically it looks to invest $10-100+ million. The firm is generalists, with significant experience in telecommunications, consumer products, industrials, financial services, and renewable energy.
ARMAVIR PARTNERS
Industry:
Finance Financial Services Venture Capital
Founded:
2018-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
SPF Microsoft Azure DNS Proofpoint DNS Made Easy DNS Salesforce SPF My Salesforce DNS Made Easy Tiggee Adobe Connect SpyCloud
Similar Organizations
Color Capital
Color Capital invests in things people buy, and how they buy them.
CYwP Fund
CYwP Fund offers growth capital through debt and equity investments in operating companies and high-yield real estate opportunities.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-01-01 | CALDER GROUP | ArmaVir Partners investment in Private Equity Round - CALDER GROUP | N/A |
| 2019-05-15 | NJOY | ArmaVir Partners investment in Private Equity Round - NJOY | 15 M USD |
| 2019-04-22 | PAX Labs | ArmaVir Partners investment in Venture Round - PAX Labs | 420 M USD |
| 2019-01-30 | NJOY | ArmaVir Partners investment in Private Equity Round - NJOY | 22 M USD |
| 2012-07-25 | Bluebird Bio | ArmaVir Partners investment in Series D - Bluebird Bio | 60 M USD |
| 2010-09-24 | Cascadian Therapeutics | ArmaVir Partners investment in Post-IPO Equity - Cascadian Therapeutics | 14.9 M USD |
| 2010-03-16 | Biomoda | ArmaVir Partners investment in Venture Round - Biomoda | 1000 K USD |
| 2010-02-24 | SinoHub | ArmaVir Partners investment in Venture Round - SinoHub | 4.61 M USD |
| 2009-08-20 | CEL-SCI | ArmaVir Partners investment in Post-IPO Equity - CEL-SCI | 4.4 M USD |
| 2005-08-16 | BravoSolution | ArmaVir Partners investment in Venture Round - BravoSolution | 6.5 M USD |